Needham & Company LLC Reaffirms “Buy” Rating for Vir Biotechnology (NASDAQ:VIR)
Vir Biotechnology (NASDAQ:VIR – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at Needham & Company LLC in a research note issued to investors on Thursday,Benzinga reports. They presently have a $19.00 price target on the stock. Needham & Company LLC’s price target points to a potential upside of 126.46% from […]
Vir Biotechnology (NASDAQ:VIR – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at Needham & Company LLC in a research note issued to investors on Thursday,Benzinga reports. They presently have a $19.00 price target on the stock. Needham & Company LLC’s price target points to a potential upside of 126.46% from […]
